Abstract
P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have